Skip to content

The Bipolar Lithium Imaging Scan Study: imaging lithium in the brain of BD patients.

The Bipolar Lithium Imaging Scan Study: imaging lithium in the brain of BD patients. - BLISS

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON53664
Enrollment
80
Registered
2022-05-18
Start date
2024-03-13
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bipolar disorder

Interventions

This is not an interventional study.

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Aged 18 years or aboveClinically diagnosed with bipolar disorder type I or II and confirmed BD diagnosis according to the CIDI Starting lithium treatment as part of their regular treatmentWritten informed consent 

Exclusion criteria

Exclusion criteria: Participants who cannot read, speak or understand Dutch Unable to provide informed consent: this will be assessed during the informed consent procedure by trained research personnel. When in doubt, they will be able to consult a clinician.Drug or alcohol abuse over a period of 2 weeks prior to the experimentContra-indications for an MRI/MRSI

Design outcomes

Primary

MeasureTime frame
The primary outcome is the clinical response to lithium treatment at 1 year follow-up, assessed using a validated questionnaire. Linear regression analysis will be used to establish correlations between brain lithium concentrations—measured through mean brain, voxel-wise, parcellation, and region-of-interest approaches—and clinical lithium response.

Secondary

MeasureTime frame
Serum lithium levels: correlations with mean brain lithium concentrations will be determined.  

Countries

Netherlands

Contacts

Public ContactE Boere

Leids Universitair Medisch Centrum

bliss@lumc.nl071-5263785

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)